The best minds in cancer research and virtual reality are coming together to create an original product to help cancer patients – and you can be a part of it by backing it! Dr Jacqueline Hall, a leading mind in cancer research, and Stefano Bianchi, a VR specialist, want to fund a personalised VR experience for patients to use while undergoing chemotherapy to reduce fear and stress. They have already started work on a basic version and tested it on patients.
The best minds in cancer research and virtual reality are coming together to create an original product to help cancer patients – and you can be a part of it by backing it! Dr Jacqueline Hall, a leading mind in cancer research, and Stefano Bianchi, a VR specialist, want to fund a personalised VR experience for patients to use while undergoing chemotherapy to reduce fear and stress. They have already started work on a basic version and tested it on patients. The response was very positive and has spurred them on to go further. However, funding is required to develop a comprehensive first version to test, and then following certification it will be able to be rolled out to patients for free. Why support Anywhere Else: Cancer treatment causes psychological stress. The VR experience is designed to temporarily immerse patients into another world to help improve their quality of life. Anywhere Else is personalised to the user’s preference and age to make the treatment less distressing. If you take, for instance, a child who is experiencing treatment it can be extremely daunting having treatment for hours in a hospital. A VR headset can take them to a child-friendly world, where it’s not as scary. Dr Jacqueline Hall explains more: “The Anywhere Else VR experience is all about improving the experience for those undergoing cancer treatment. Anything we can do to reduce the feelings of loneliness and distress for people going through this is good for our patients wellbeing. Working with Stefano, a leading VR mind who is passionate about making the lives of cancer patients better, means that together – and with your support – we can make a big difference.”
More information about the people behind this project to life:
STEFANO BIANCHI, CEO, IT IS THE END
Stefano is originally from Turin, Italy. After graduating in Graphic Design, he developed skills in VR and AR through working in agencies and learning in his own time. It was his passion and ability to inspire, that led him to be a regular guest lecturer of game design, digital publishing and VR/AR at IED (Istituto Europeo di Design). Stefano has worked for a range of companies and agencies in the last 21 years, and this expertise has all gone into his business, It Is The End LTD, founded in 2018. The company works on digital research and development with a focus on innovation and problem solving. VR and AR are the main activities of the business and they have worked with many clients including Xerjoff, a luxury brand, but the company is also keen to be involved in projects that use these technologies to have a positive impact on social problems and quality of life. This particular project is really close to Stefano’s heart because of direct experience and he is excited about the positive impact this technology can have on people suffering with cancer. Stefano’s leadership and experience in this field will see him being a guest speaker at the 2020 Horasis Global Meeting discussing ‘Developing Decisive Leadership theme through Times of Disruption’.
DR HALL BIO (VR)
Dr Jacqueline Hall has a PhD in cancer research and has spent more than 15 years working in cancer research and drug discovery and development. After completing her PhD in Scotland, UK and two years postdoctoral research in Canada, Dr Hall worked for a not for profit cancer organisation called the European Organisation for Research and Treatment in Cancer (EORTC) in Brussels for 5 years, transforming traditional clinical trials to personalised medicine studies with cancer treatments targeted to specific molecular aberrations within tumour cells. She also helped to establish processes to support European translational research studies in cancer and worked with several EU programs to achieve this. Dr Hall went on to help found be the Director of a new not-for-profit organisation in Luxembourg called the International Quality Network for Pathology (IQN Path ASBL) which has the mission to improve and support high quality cancer diagnostic testing in pathology worldwide. Dr Hall has also worked in large scale DNA sequencing programmes and worked with an American genomics company Seven Bridges Genomics providing software solutions for large scale biomedical data analysis and also has an interest in digital pathology. Throughout her career Dr Hall has always maintained close links to patient advocacy groups, working with patients to achieve the goals that matter when it comes to cancer treatment and cancer research.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.